EP Patent

EP2322200A2 — Compositions and methods for the treatment of immune related diseases

Assigned to Genentech Inc · Expires 2011-05-18 · 15y expired

What this patent protects

The present invention relates to compositions containing novel proteins and methods of using those compositions for the diagnosis and treatment of immune related diseases.

USPTO Abstract

The present invention relates to compositions containing novel proteins and methods of using those compositions for the diagnosis and treatment of immune related diseases.

Drugs covered by this patent

Patent Metadata

Patent number: EP2322200A2
Jurisdiction: EP
Classification: —
Expires: 2011-05-18
Drug substance claim: No
Drug product claim: No
Assignee: Genentech Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.